Role of the Cancer Registry and Pathology Informatics in the Cancer

Role of the Cancer Registry and Pathology Informatics in the Cancer

Role of the Cancer Registry and P athology Infor m atics in the Cancer Center N A A C C R Cancer Infor m atics Sy m posiu m: Essential Technologies & M ethodologies for Registries Toronto, Canada; Sunday, June 9th, 2002 Michael J. Becich, M D Ph D - becich@ pitt.edu C hair m an of Pathology, UP M C-Shadyside & Hillm a n Cancer Center Associate Professor of Pathology and Infor ma tion Sciences & Teleco m m u nications U niversity of Pittsburgh School Medicine Director, Center for Path ology Inform atics http://path.up mc.edu/cpi Director, Benedu m Oncology Infor matics Center (Hill m an Cancer Center) http:// w w w.upci.up mc.edu/internet/benedu m /index.ht ml Advancing Pathology Infor matics, Imaging and the Internet (APIII) - http://apiii.up mc.edu Association for Pathology Infor matics (API) - http:// w w w.pathologyinforSlide 1 matics.org Benedu m Oncology Informatics Center / Center for Pathology Infor matics 1 OO utline utline •• Introduction to Oncology & Pathology Informatics R esearch at Hillman Cancer Center •• Linkages Between Pathology and Cancer Registries •• Research Use of Pathology Data and Cancer Registries •• Co m prehensive Prostate Cancer Tissue Resource (C P C T R) an d Tissue B a n k Inform ation Syste m s [Clinical, Pathology & Cancer Registry Data] •• The Shared Pathology Informatics Network (SPIN) - Cancer Registry and Anato mic Pathology Data •• Conclusions •• Future Directions – T h e N ee d for Electronic C o m m u nication Strategies Slide 2 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 2 HillmanHillman CancerCancer CenterCenter University of Pittsburgh Cancer Institute and UP M C Cancer Centers Co m prehensive Cancer Center 12 patient care centers, each focusing on a specific typ e or treatm e nt of can cer N ationally a n d Re gion ally Co m p etitive In stitutio n siz e 600+ physicians/researchers N u m b er of ne w cancer patients per year: 10,00 0 + P a rticip atio n in clinic al trials Number of open protocols by sponsor type 247 active protocols (48 phar m aceutical, 28 cooperative group, 45 internal) Number of patients accrued in 2001: 1028 Slide 3 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 3 HillmanHillman CancerCancer CenterCenter P athology Infor m atics 1 8 hospitals – one anato mic laboratory infor m ation syste m (LIS) 1 2 of 1 8 ho s pitals on o n e clinic al path olo g y LI S One tissue banking plan (5 major tissue banks) and no w linked to our Organ Specific Database progra m O ncology Infor matics 1 4 of 1 8 ho s pital on o n e C a n c e r R e gistry (I m P at h, for m erly M R S) N u m ber of ne w index cancer patients per year: 10,000+ Clinical Trials Inform ation Syste m (develope d in house) Organ Specific Databases (research infor mation syste ms) Slide 4 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 4 OO utline utline •• Introduction to Oncology & Pathology Informatics R esearch at Hillman Cancer Center •• Linkages Between Pathology and Cancer Registries •• Research Use of Pathology Data and Cancer Registries •• Co m prehensive Prostate Cancer Tissue Resource (C P C T R) an d Tissue B a n k Inform ation Syste m s [Clinical, Pathology & Cancer Registry Data] •• The Shared Pathology Informatics Network (SPIN) - Cancer Registry and Anato mic Pathology Data •• Conclusions •• Future Directions – T h e N ee d for Electronic C o m m u nication Strategies Slide 5 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 5 PP at at h h olo olo g g y y InforInfor m m atics atics Grade • Seventy percent of the data in Stage the U P M C Electronic Me dical Progression PSA Record is Pathology Data Therapy Type D e m o graphics • Eighty percent of the data us e d Pathology by the UPMC decision support Clinical Genetic syste m is Pathology Data Morphologic G ene Expression• Seventy-plus percent of the Genotype queries against the UPMC EMR Anatomy involve Pathology Data Phenotype • Ti m e P athologists analyze blood and tissue for the prese nce a n d nature of disease • M u c h of this analysis is based or relies on morphology Slide 6 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 6 MM erging erging PathologyPathology && OncologyOncology DataData forfor ValueValue CreationCreation • Pathology & Oncology Data and Value Creation: – Tissue In B ased Archives » Paraffin – Tu mor classification, staging & grading (stored in anato mic pathology lab info syste m or A P LIS) are critical to the Molecular ReClassification (NCI Director’s Challenge) » Cancer Registry (CR) records treat m ent, progression and outco mes critical to res e arc h efforts (S PI N gra nt) » I m p orta n c e of res e arc h m a t erials (tissues) for geno mics » Pathology + O utco mes + Tissue = unprecedented new value – Clinical Data (and Seru m) Archives » Chemistry profiles and tumor markers many times qualify a patient or define success or failure of therapeutic intervention in clinical trials (clinical pathology lab info syste m or CPLIS) » Aggregates of longitudinal medical records in Oncology and for hospital syste ms (clinical infor m ation system s or CIS) has new perceived value for bench marking change Slide 7 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 7 CoCo mponent mponent TechnologyTechnology –– PP athology athology && OO ncology ncology InforInfor m m atics atics •• PathologyPathology InformInform atics atics •• OncologyOncology InformInform atics atics •• AA n n ato ato mic mic PatholoPatholo gy gy •• CancerCancer RegistryRegistry •• ClinicalClinical PathologyPathology •• ClinicalClinical TrialsTrials •• HH e e m m atopathology atopathology && •• OO r r ga ga n n SpSp ecific ecific MM olecular olecular DiagnosticsDiagnostics PrograProgra m m SupportSupport •• LILI M M S S forfor GenoGeno mics mics ••Prostate, andand ProteoProteo mics mics M elano ma, etc.. • •• TissueTissue BankingBanking • TelemedicineTelemedicine (for(for •• oncology)oncology) TelepathologyTelepathology •• •• WW e e b b SiteSite SupportSupport WW e e b b SiteSite SupportSupport •• EE--HealthHealth Slide 8 InitiativesInitiatives Benedu m Oncology Informatics Center / Center for Pathology Infor matics 8 ProposedProposed InforInfor mation mation RR el el atio atio n n s s hi hi p p s s Version 1.0 Synoptic Form s Cancer Pathology R e gistry LIS Nomenclature HL7 R esearch Infor m a tion Tissue B a nk System Slide 9 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 9 RR esearch esearch InforInfor mation mation SysteSyste m m • This syste m acts as an integrator, verifier and honest Cancer Pathology R e gistry LIS broker N o m enclature Synoptic Forms • Version 1.04 of this syste m is Tissue Bank imple mented for prostate with Tissue Bank Infor m ation funding from CP CT R, CaPC U RE System and National Medical Test De identification Beds (NMTB) which is a DOD/TATRC (Telemedicine Organ Specific Research Dataset and Advanced Technology Research Center) funded effort. Intran et N CI interface, collaborator interfaces Slide 10 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 10 Clinical Environ m ent (Id e ntified Data) AP-LIS CP-LIS Clinical Tissue Sources Clinical Infor m ation Sources Clinician Direct Data Entry Fire w all Tissue Bank Honest Tissue Bank Infor mation Syste m Planned Broker Environ ment Cancer Registry (Clinical, Pathology & Outco mes) O ne way interface Fire w all De-identified Data O nly R e s e arch E nviron m e nt (De-identified Data) Organ Specific Research Database R esearch Infor m ation Sources Syste ms Interface cD N A Microarrays Tissue Microarrays Imaging Data (not com pleted) Research Data Server Intra n et A n alysis an d Visualization S ervers (years 2 - 3) Figure 1: Overall architecture OO utline utline •• Introduction to Oncology & Pathology Informatics R esearch at Hillman Cancer Center •• Linkages Between Pathology and Cancer Registries •• Research Use of Pathology Data and Cancer Registries •• Co m prehensive Prostate Cancer Tissue Resource (C P C T R) an d Tissue B a n k Inform ation Syste m s [Clinical, Pathology & Cancer Registry Data] •• The Shared Pathology Informatics Network (SPIN) - Cancer Registry and Anato mic Pathology Data •• Conclusions •• Future Directions – T h e N ee d for Electronic C o m m u nication Strategies Slide 12 Benedu m Oncology Informatics Center / Center for Pathology Infor matics 12 Current Funding and AP-LIS CP-LIS Areas of Influence Clinical Environ m ent (Id e ntified Data) Clinical Tissue Sources Clinical Infor m ation Sources Clinician Direct D ata E ntry De-ID (Clinical Research Infor m ation Service or CRIS) SPIN – Shared Pathology U M LS Based Parser and Autocoder – SPIN Infor m atics Network T w o W ay Hashing for Non-Consented Clinfo and Biosa mples Fire w all Tissue Bank Honest Tissue Bank Infor mation Syste m Planned C P C T R – Cooperative Prostate Broker Environ ment Cancer Registry (Clinical, Pathology & Outco mes) Cancer Tissue Resource One way interface Fire w all De-identified D ata O nly R e s e arch E nviron m e nt Director’s Challenge – Molecular (De-identified Data) R e Classification of Diseas e Organ Specific Research Database R esearch Infor m ation Sources Syste ms Interface Prostate Research Dataset cDNA Microarrays Tissue Microarrays Imaging Data (not co m pleted) Research Data Server Intra n et A n alysis an d Visualization Servers (years 2 -3) Figure 2: Tissue Cube Director’sDirector’s ChallengeChallenge –– MM olecular olecular

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    44 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us